BioSpace News Archive

Intellipharmaceutics Provides Operational Update - Jan. 24, 2018

The company provided an operational update on its plans and projected timelines for the 2018 year.

January 24, 2018
·
14 min read
Policy

CAO Group Protects its Diode Laser Patent Rights From Infringement by Biolase

CAO Group has filed patent infringement lawsuits in the United States District Court for the State of Utah and in the United States District Court for the Central District of California against Biolase.

January 24, 2018
·
2 min read
Promising Results From Study Show That Zero-Calorie Prebiotic Sweeteners Could Replace Sugar in Food and Drink Products

These results suggest that the natural, zero-calorie, healthy prebiotic sweeteners could work as bulk sugar replacements in a wide range of food and drink products.

January 24, 2018
·
3 min read
BioForest

Cocrystal Pharma Provides Update on Reverse Stock Split

The reverse stock split will be effective with the opening of trading on the OTCQB Market on Wednesday, January 24, 2018.

January 24, 2018
·
4 min read
Pharm Country

UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option

Jefferies LLC and Cowen and Company, LLC acted as joint book-running managers for the offering. Oppenheimer & Co. Inc. acted as lead manager for the offering.

January 24, 2018
·
3 min read
Business

Advicenne Appoints Linda Law, MD as U.S. VP, Clinical Development

Dr. Law will oversee Advicenne’s clinical development and medical affairs efforts in North America which are focused on the Company’s most advanced program, ADV7103.

January 24, 2018
·
2 min read
Biotech Bay

Ultragenyx Announces Pricing of Public Offering of Common Stock

The offering is expected to close on or about January 26, 2018, subject to satisfaction of customary closing conditions.

January 24, 2018
·
4 min read
Business

Sanofi: Availability of the Pre-quarterly Results Communication - Jan. 24, 2018

Each quarter, Sanofi prepares this document to assist in the financial modeling of the Group’s quarterly results.

January 24, 2018
·
3 min read
Policy

FDA Has Approved Faron’s Traumakine IND

The FDA has already proposed that Faron can proceed directly to BLA pending positive results from the two on-going Phase III trials

January 24, 2018
·
3 min read
Poietis Announces the First Commercial Launch of a Tissue Model Manufactured by Bioprinting

Poietis, a leading company in 4D bioprinting solutions, today announces the commercial launch of Poieskin, its first bioprinted skin model.

January 24, 2018
·
2 min read